Schechter Investment Advisors LLC Has $1.64 Million Position in Sanofi (NASDAQ:SNY)

Schechter Investment Advisors LLC cut its holdings in Sanofi (NASDAQ:SNY) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 33,918 shares of the company’s stock after selling 367 shares during the period. Schechter Investment Advisors LLC’s holdings in Sanofi were worth $1,636,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in SNY. Synergy Asset Management LLC bought a new stake in shares of Sanofi in the fourth quarter valued at approximately $25,000. McClarren Financial Advisors Inc. raised its stake in Sanofi by 952.6% during the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock valued at $28,000 after purchasing an additional 543 shares during the last quarter. Sunbelt Securities Inc. lifted its stake in shares of Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after buying an additional 313 shares during the period. Sierra Ocean LLC bought a new stake in shares of Sanofi in the 4th quarter worth approximately $44,000. Finally, Versant Capital Management Inc bought a new position in Sanofi in the fourth quarter worth $54,000. Institutional investors own 14.04% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on SNY. Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $60.00.

Sanofi Stock Performance

Shares of NASDAQ:SNY opened at $56.52 on Tuesday. The business has a fifty day moving average of $51.81 and a 200-day moving average of $52.61. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46. Sanofi has a twelve month low of $45.22 and a twelve month high of $58.97. The firm has a market cap of $143.44 billion, a PE ratio of 22.70, a price-to-earnings-growth ratio of 1.01 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, equities research analysts predict that Sanofi will post 4.36 EPS for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.